192 results
Page 3 of 10
8-K
EX-99.1
n4xvllpz7ig02gv jgqa
10 Nov 22
Moleculin Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
4:11pm
8-K
EX-99.1
5v77md49dnspy
14 Oct 22
Moleculin Provides Update on Second Multiple Ascending Dose (MAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:40am
8-K
EX-99.1
m53t2khksgif2d gz87x
27 Sep 22
Regulation FD Disclosure
8:36am
8-K
EX-99.1
1cuz w6tn5v
6 Sep 22
Moleculin Receives FDA Orphan Drug Designation of WP1122 for the Treatment of Glioblastoma Multiforme
8:45am
8-K
EX-99.1
3419yus1k30q8f2ggy5
19 Aug 22
Moleculin Announces Completion of Third Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:40am
8-K
EX-99.1
025p0
15 Aug 22
Moleculin Reports Second Quarter 2022 Financial Results and Provides Programs Update
8:48am
8-K
EX-99.1
3i3ti5f o869w
28 Jul 22
Regulation FD Disclosure
8:35am
8-K
EX-99.1
tuhn0q
8 Jul 22
Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:37am
8-K
EX-99.1
b45w ty9m4uns
16 Jun 22
Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:35am
8-K
EX-99.1
5hc5g3
26 May 22
Moleculin Commences Dosing in Healthy Volunteers in Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19
8:35am
8-K
EX-99.1
6u07i01c4u49
12 May 22
Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update
8:35am
8-K
EX-99.1
d8z8whh0w
10 May 22
Regulation FD Disclosure
8:35am
8-K
EX-99.1
mvfjefglcyamxd
5 May 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
iv41g515yju4gab
4 May 22
Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer
8:15am
8-K
EX-99.1
s67c 3mwp
21 Apr 22
Moleculin Receives IND Clearance to Conduct Phase 1 Study of WP1066 for the Treatment of Recurrent Malignant Glioma
8:45am
8-K/A
EX-99.1
0rxyre ms
12 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
8:57am
8-K
EX-99.1
lpixjorhbd3jc0b
8 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
4:32pm
8-K
EX-99.1
ytgxjejdr2jg1hej
25 Mar 22
Moleculin Reports Full Year Financial Results and Provides Programs Update
7:05am